Brief: Orexo's Zubsolv Added To NY State Medicaid Mat Preferred Drug List

Orexo AB

24/02/2022 07:23

Feb 24 (Reuters) - Orexo AB  ORX.ST :
    * OREXO'S LEAD PRODUCT ZUBSOLV® ADDED TO NY STATE MEDICAID
MAT
PREFERRED DRUG LIST
    * ZUBSOLV® WILL BE AVAILABLE TO ALL PATIENTS WITH MEDICAID
INSURANCE IN NY STATE EFFECTIVE MARCH 22, 2022
    * ZUBSOLV® MARKET ACCESS IMPROVES IN PUBLIC SEGMENT TO 48
PERCENT
UNRESTRICTED ACCESS FROM 42 PERCENT CURRENTLY
    * ZUBSOLV® MAINTAINS UNRESTRICTED ACCESS TO OVER 98 PERCENT
OF
PATIENTS IN COMMERCIAL SEGMENT

Source text for Eikon:  ID:nWkr9zrF81 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))